These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 32621635)
21. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies. Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016 [TBL] [Abstract][Full Text] [Related]
22. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118 [TBL] [Abstract][Full Text] [Related]
23. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
24. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression. Rodriguez-Martinez L; García-Moreno C; Perez-Pampin E; Gómara MJ; Sarmiento-Monroy JC; Lopez-Golán Y; Gómez-Puerta JA; Mera-Varela A; Conde C; Sanmartí R; Haro I; González A Arthritis Res Ther; 2023 Oct; 25(1):192. PubMed ID: 37798800 [TBL] [Abstract][Full Text] [Related]
25. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts. Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441 [TBL] [Abstract][Full Text] [Related]
26. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients. Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241 [TBL] [Abstract][Full Text] [Related]
27. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Fechtner S; Berens H; Bemis E; Johnson RL; Guthridge CJ; Carlson NE; Demoruelle MK; Harley JB; Edison JD; Norris JA; Robinson WH; Deane KD; James JA; Holers VM Arthritis Rheumatol; 2022 Apr; 74(4):597-603. PubMed ID: 34605217 [TBL] [Abstract][Full Text] [Related]
28. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
29. Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis. Zheng Z; Mergaert AM; Fahmy LM; Bawadekar M; Holmes CL; Ong IM; Bridges AJ; Newton MA; Shelef MA Arthritis Rheumatol; 2020 Feb; 72(2):262-272. PubMed ID: 31397047 [TBL] [Abstract][Full Text] [Related]
30. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
31. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976 [TBL] [Abstract][Full Text] [Related]
32. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis. Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362 [TBL] [Abstract][Full Text] [Related]
33. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516 [TBL] [Abstract][Full Text] [Related]
35. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J; Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545 [TBL] [Abstract][Full Text] [Related]
36. The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients. Gomez EL; Gun SC; Somnath SD; D'Souza B; Lim AL; Chinna K; Radhakrishnan AK Int J Rheum Dis; 2011 Feb; 14(1):12-7. PubMed ID: 21303477 [TBL] [Abstract][Full Text] [Related]
37. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Majka DS; Deane KD; Parrish LA; Lazar AA; Barón AE; Walker CW; Rubertone MV; Gilliland WR; Norris JM; Holers VM Ann Rheum Dis; 2008 Jun; 67(6):801-7. PubMed ID: 17974596 [TBL] [Abstract][Full Text] [Related]
38. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor. Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477 [TBL] [Abstract][Full Text] [Related]
39. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients. Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876 [TBL] [Abstract][Full Text] [Related]
40. Are the cut-offs of the rheumatoid factor and anti-cyclic citrullinated peptide antibody different to distinguish rheumatoid arthritis from their primary differential diagnoses? Pineda-Sic RA; Vega-Morales D; Santoyo-Fexas L; Garza-Elizondo MA; Mendiola-Jiménez A; González Marquez KI; Carrillo-Haro B Int J Immunogenet; 2024 Feb; 51(1):1-9. PubMed ID: 37933209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]